MoneyWorks4Me

Omkar Pharmachem submits copy of limited review report

07 Nov 2012 Evaluate
Omkar Pharmachem has submitted a copy of the limited review report for the period ended September 30, 2012.

The above information is a part of company's filings submitted to BSE.
Peers
Company Name CMP
Sagility 45.45
Prime Focus 271.05
Knowledge RealtyTrt. 112.26
Indegene 588.15
Syngene Internatl. 372.60
View more..